Atlas Trials

Mass Balance, Pharmacokinetics and Metabolism Study of Alisertib

Clinical trial NCT01714947 · COMPLETED

Trial details

NCT number
NCT01714947
Sponsor
Millennium Pharmaceuticals, Inc.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Advanced Solid TumorsLymphoma
Start date
2013-01-24
Primary completion
2013-04-04
Enrollment
3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.